Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;7(6):e2201605.
doi: 10.1002/smtd.202201605. Epub 2023 Mar 12.

CRISPR/Cas9 Screen in Gastric Cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability

Jovan Mircetic  1   2 , Aylin Camgöz  3   4   5   6   7 , Moustafa Abohawya  1 , Li Ding  8 , Julia Dietzel  2 , Sebastián García Tobar  2   9 , Maciej Paszkowski-Rogacz  8 , Therese Seidlitz  9 , Tim Schmäche  4   5   6   7   9 , Marie-Christin Mehnert  2 , Olga Sidorova  8   10 , Jürgen Weitz  4   5   6   7   9 , Frank Buchholz  4   5   6   7   8 , Daniel E Stange  1   4   5   6   7   9
Affiliations

CRISPR/Cas9 Screen in Gastric Cancer Patient-Derived Organoids Reveals KDM1A-NDRG1 Axis as a Targetable Vulnerability

Jovan Mircetic et al. Small Methods. 2023 Jun.

Abstract

Viability CRISPR screens have proven indispensable in parsing genome function. However, their application in new, more physiologically relevant culturing systems like patient-derived organoids (PDOs) has been much slower. To probe epigenetic contribution to gastric cancer (GC), the third leading cause of cancer-related deaths worldwide, the first negative selection CRISPR screen in GC PDOs that faithfully preserve primary tumor characteristics is performed. Extensive quality control measurements showing feasibility of CRISPR screens in primary organoid culture are provided. The screen reveals the histone lysine demethylase-1A (KDM1A) to constitute a GC vulnerability. Both genetic and pharmacological inhibition of KDM1A cause organoid growth retardation. Further, it is shown that most of KDM1A cancer-supporting functions center on repression of N-myc downstream regulates gene-1 (NDRG1). De-repression of NDRG1 by KDM1A inhibitors (KDM1Ai) causes inhibition of Wnt signaling and a strong G1 cell cycle arrest. Finally, by profiling 20 GC PDOs, it is shown that NDRG1 upregulation predicts KDM1Ai response with 100% sensitivity and 82% specificity in the tested cohort. Thus, this work pioneers the use of negative selection CRISPR screens in patient-derived organoids, identifies a marker of KDM1Ai response, and accordingly a cohort of patients who may benefit from such therapy.

Keywords: CRISPR screen; KDM1A-NDRG1 axis; epigenetic regulators; gastric cancer; patient-derived organoids.

PubMed Disclaimer

References

    1. C. Fitzmaurice, D. Abate, N. Abbasi, H. Abbastabar, F. Abd-Allah, O. Abdel-Rahman, A. Abdelalim, A. Abdoli, I. Abdollahpour, A. S. M. Abdulle, N. D. Abebe, H. N. Abraha, L. J. Abu-Raddad, A. Abualhasan, I. A. Adedeji, S. M. Advani, M. Afarideh, M. Afshari, M. Aghaali, D. Agius, S. Agrawal, A. Ahmadi, E. Ahmadian, E. Ahmadpour, M. B. Ahmed, M. E. Akbari, T. Akinyemiju, Z. Al-Aly, A. M. AlAbdulKader, F. Alahdab, et al., JAMA Oncology 2019, 5, 1749.
    1. R. H. Hunt, M. Camilleri, S. E. Crowe, E. M. El-Omar, J. G. Fox, E. J. Kuipers, P. Malfertheiner, K. E. L. McColl, D. M. Pritchard, M. Rugge, A. Sonnenberg, K. Sugano, J. Tack, Gut 2015, 64, 1650.
    1. R. J. Epistola, J. Chao, Transl. Gastroenterol. Hepatol. 2020, 5, 53.
    1. Y.-J. Bang, E. V. Cutsem, A. Feyereislova, H. C. Chung, L. Shen, A. Sawaki, F. Lordick, A. Ohtsu, Y. Omuro, T. Satoh, G. Aprile, E. Kulikov, J. Hill, M. Lehle, J. Rüschoff, Y.-K. Kang, Investigators Lancet 2010, 376, 687.
    1. C. S. Fuchs, J. Tomasek, C. J. Yong, F. Dumitru, R. Passalacqua, C. Goswami, H. Safran, L. V. dos Santos, G. Aprile, D. R. Ferry, B. Melichar, M. Tehfe, E. Topuzov, J. R. Zalcberg, I. Chau, W. Campbell, C. Sivanandan, J. Pikiel, M. Koshiji, Y. Hsu, A. M. Liepa, L. Gao, J. D. Schwartz, J. Tabernero, Lancet 2014, 383, 31.

LinkOut - more resources